Get the latest tech news

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

Moderna and Merck say their personalized mRNA melanoma vaccine significantly reduced both cancer recurrence and spread in a late-stage trial. The treatment could reach patients as soon as next year if regulators approve it. Reuters reports: Moderna developed the vaccine with Merck and tested it tog...

None

Get the Android app